IBS is a functional bowel disorder characterized by abdominal pain and more. Darren Brenner, MD, and a colleague highlight the pivotal efficacy and safety data of the three pharmacologic agents currently indicated in the USA for the management of IBS-D. ht
RT @NMGastro: Darren Brenner, MD, and a colleague review the pivotal efficacy and safety data of the three pharmacologic agents currently i…
Darren Brenner, MD, and a colleague review the pivotal efficacy and safety data of the three pharmacologic agents currently indicated in the USA for the management of IBS-D in adults. Read more> https://t.co/aGhy9MAA6r
Darren Brenner, MD, and a colleague review the pivotal efficacy and safety data of the three pharmacologic agents currently indicated in the USA for the management of IBS-D in adults. Read more> https://t.co/WI0KJSmXdJ via @AdvancesTherapy
Darren Brenner, MD, reviewed the pivotal efficacy and safety data of the three pharmacologic agents currently indicated in the USA for the management of IBS-D in adults. https://t.co/NxdkRK3xW4
RT @microbe_article: Current us food and drug administration-approved pharmacologic therapies for the treatment of irritable bowel syndrome…
Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea. https://t.co/GsTzbSQPtM
Current us food and drug administration-approved pharmacologic therapies for the treatment of irritable bowel syndrome wi... - Brenner DM et al. - https://t.co/7ItRqoImsG #microbiome